T-CELL LYMPHOPROLIFERATIVE DISORDER FOLLOWING MYCOPHENOLATE TREATMENT FOR MYASTHENIA GRAVIS

    loading  Checking for direct PDF access through Ovid

Abstract

Immunosuppressive therapies are critical in the management of numerous conditions including myasthenia gravis. Mycophenolate mofetil is a widely used, oral immunosuppressive agent that is considered to have few adverse effects compared with similar drugs. We report the case of a patient who developed T-cell lymphoproliferative lesions following long-term treatment with mycophenolate mofetil and prednisone for myasthenia gravis. The lesions resolved following cessation of the treatment. This case highlights a serious complication of a commonly used drug. Muscle Nerve, 2009

Related Topics

    loading  Loading Related Articles